IKAROS isoform 6 enhances BCR-ABL1-mediated proliferation of human CD34 + hematopoietic cells on stromal cells

International Journal of Oncology

Volumn 40, Issue 1, 2012, Pages 53-62

  Suzuki, Kei ^a   Ono, Ryoichi ^a   Ohishi, Kohshi ^a,b   Masuya, Masahiro ^a   Kataoka, Itaru ^c   Liu, Bing ^a   Nakamori, Yoshiki ^a   Ino, Kazuko ^a   Monma, Fumihiko ^a   Hamada, Hirofumi ^d   Kitamura, Toshio ^e   Katayama, Naoyuki ^a   Nosaka, Tetsuya ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b MIE UNIVERSITY HOSPITAL   (Japan)

^c OKAYAMA UNIVERSITY   (Japan)

^d SAPPORO MEDICAL UNIVERSITY   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

Author keywords

Acute leukemia; BCR ABL; CD34 + cells; IKAROS; Stromal cells

Indexed keywords

BCR ABL PROTEIN; IKAROS TRANSCRIPTION FACTOR;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; CD34 SELECTION; CELL PROLIFERATION; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; ERYTHROID PRECURSOR CELL; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKEMOGENESIS; PHILADELPHIA CHROMOSOME POSITIVE CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA CELL; TUMOR MICROENVIRONMENT;

ANTIGENS, CD34; CELL COMMUNICATION; CELL GROWTH PROCESSES; COCULTURE TECHNIQUES; FETAL BLOOD; FUSION PROTEINS, BCR-ABL; HEMATOPOIETIC STEM CELLS; HUMANS; IKAROS TRANSCRIPTION FACTOR; PROTEIN ISOFORMS; STROMAL CELLS; TRANSDUCTION, GENETIC;

EID: 84455163100     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.1192     Document Type: Article

References (34)

1. Daley GQ, van Etten RA and Baltimore D: Blast crisis in a murine model of chronic myelogenous leukemia. Proc Natl Acad Sci USA 88: 11335-11338, 1991. (Pubitemid 21916035)
2. Williams RT, Roussel MF and Sherr CJ: Arf gene loss enhances oncogenicity and limits imatinib response in mouse models of Bcr-Abl-induced acute lymphoblastic leukemia. Proc Natl Acad Sci USA 103: 6688-6693, 2006.
3. Chalandon Y, Jiang X, Christ O, Loutet S, Thanopoulou E, Eaves A and Eaves C: BCR-ABL-transduced human cord blood cells produce abnormal populations in immunodeficient mice. Leukemia 19: 442-448, 2005. (Pubitemid 40403323)
4. Iacobucci I, Lonetti A, Messa F, Cilloni D, Arruga F, Ottaviani E, Paolini S, Papayannidis C, Piccaluga PP, Giannoulia P, Soverini S, Amabile M, Poerio A, Saglio G, Pane F, Berton G, Baruzzi A, Vitale A, Chiaretti S, Perini G, Foà R, Baccarani M and Martinelli G: Expression of spliced oncogenic Ikaros isoforms in Philadelphia-positive acute lymphoblastic leukemia patients treated with tyrosine kinase inhibitors: implications for a new mechanism of resistance. Blood 112: 3847-3855, 2008.
5. Nakayama H, Ishimaru F, Avitahl N, Sezaki N, Fujii N, Nakase K, Ninomiya Y, Harashima A, Minowada J, Tsuchiyama J, Imajoh K, Tsubota T, Fukuda S, Sezaki T, Kojima K, Hara M, Takimoto H, Yorimitsu S, Takahashi I, Miyata A, Taniguchi S, Tokunaga Y, Gondo H, Niho Y, Nakao S, Kyo T, Dohy H, Kamada N and Harada M: Decreases in Ikaros activity correlate with blast crisis in patients with chronic myelogenous leukemia. Cancer Res 59: 3931-3934, 1999. (Pubitemid 29393556)
6. Nakase K, Ishimaru F, Avitahl N, Dansako H, Matsuo K, Fujii K, Sezaki N, Nakayama H, Yano T, Fukuda S, Imajoh K, Takeuchi M, Miyata A, Hara M, Yasukawa M, Takahashi I, Taguchi H, Matsue K, Nakao S, Niho Y, Takenaka K, Shinagawa K, Ikeda K, Niiya K and Harada M: Dominant negative isoform of the Ikaros gene in patients with adult B-cell acute lymphoblastic leukemia. Cancer Res 60: 4062-4065, 2000. (Pubitemid 30636585)
7. Nishii K, Katayama N, Miwa H, Shikami M, Usui E, Masuya M, Araki H, Lorenzo F, Ogawa T, Kyo T, Nasu K, Shiku H and Kita K: Non-DNA-binding Ikaros isoform gene expressed in adult B-precursor acute lymphoblastic leukemia. Leukemia 16: 1285-1292, 2002.
8. Georgopoulos K, Moore DD and Derfler B: Ikaros, an early lymphoid-specific transcription factor and a putative mediator for T cell commitment. Science 258: 808-812, 1992.
9. Georgopoulos K, Bigby M, Wang JH, Molnar A, Wu P, Winandy S and Sharpe A: The Ikaros gene is required for the development of all lymphoid lineages. Cell 79: 143-156, 1994. (Pubitemid 24309520)
10. + cells impairs their ability to differentiate toward the B-lymphoid lineage. Blood 98: 2673-2680, 2001.
11. Wang JH, Nichogiannopoulou A, Wu L, Sun L, Sharpe AH, Bigby M and Georgopoulos K: Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation. Immunity 5: 537-549, 1996. (Pubitemid 27062064)
12. Winandy S, Wu P and Georgopoulos K: A dominant mutation in the Ikaros gene leads to rapid development of leukemia and lymphoma. Cell 83: 289-299, 1995.
13. Molnár A, Wu P, Largespada DA, Vortkamp A, Scherer S, Copeland NG, Jenkins NA, Bruns G and Georgopoulos K: The Ikaros gene encodes a family of lymphocyte-restricted zinc finger DNA binding proteins, highly conserved in human and mouse. J Immunol 156: 585-592, 1996. (Pubitemid 26028917)
14. Sun L, Liu A and Georgopoulos K: Zinc finger-mediated protein interactions modulate Ikaros acitivity, a molecular control of lymphocyte development. EMBO J 15: 5358-5369, 1996. (Pubitemid 26336218)
15. Ruiz A, Williams O and Brady HJ: The Ikaros splice isoform, Ikaros 6, immortalizes murine haematopoietic progenitor cells. Int J Cancer 123: 1240-1245, 2008.
16. Mullighan CG, Miller CB, Radtke I, Phillips LA, Dalton J, Ma J, White D, Hughes TP, Le Beau MM, Pui CH, Relling MV, Shurtleff SA and Downing JR: BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature 453: 110-114, 2008. (Pubitemid 351630327)
17. Iacobucci I, Storlazzi CT, Cilloni D, Lonetti A, Ottaviani E, Soverini S, Astolfi A, Chiaretti S, Vitale A, Messa F, Impera L, Baldazzi C, D'Addabbo P, Papayannidis C, Lonoce A, Colarossi S, Vignetti M, Piccaluga PP, Paolini S, Russo D, Pane F, Saglio G, Baccarani M, Foà R and Martinelli G: Identification and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1-positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell'Adulto Acute Leukemia Working Party (GIMEMA AL WP). Blood 114: 2159-2167, 2009.
18. Virely C, sMoulin S, Cobaleda C, Lasgi C, Alberdi A, Soulier J, Sigaux F, Chan S, Kastner P and Ghysdael J: Haploinsufficiency of the IKZF1 (IKAROS) tumor suppressor gene cooperates with BCR-ABL in a transgenic model of acute lymphoblastic leukemia. Leukemia 24: 1200-1204, 2010.
19. Sezaki N, Ishimaru F, Takata M, Tabayashi T, Nakase K, Kozuka T, Fujii K, Nakayama H, Teshima T, Harada M and Tanimoto M: Over-expression of the dominant-negative isoform of Ikaros confers resistance to dexamethasone-induced and anti-IgM-induced apoptosis. Br J Haematol 121: 165-169, 2003. (Pubitemid 36461284)
20. Mullighan CG, Su X, Zhang J, Radtke I, Phillips LA, Miller CB, Ma J, Liu W, Cheng C, Schulman BA, Harvey RC, Chen IM, Clifford RJ, Carroll WL, Reaman G, Bowman WP, Devidas M, Gerhard DS, Yang W, Relling MV, Shurtleff SA, Campana D, Borowitz MJ, Pui CH, Smith M, Hunger SP, Willman CL and Downing JR, Children's Oncology Group: Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N Engl J Med 360: 470-480, 2009.
21. Martinelli G, Iacobucci I, Storlazzi CT, Vignetti M, Paoloni F, Cilloni D, Soverini S, Vitale A, Chiaretti S, Cimino G, Papayannidis C, Paolini S, Elia L, Fazi P, Meloni G, Amadori S, Saglio G, Pane F, Baccarani M and Foà R: IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report. J Clin Oncol 27: 5202-5207, 2009.
22. BCR-ABL activity in transduced primary human hematopoietic cells controls lineage programming. Blood 99: 3197-3204, 2002.
23. + cells induces similar gene expression profiles and results in a STAT5-dependent expansion of the erythroid lineage. Exp Hematol 37: 367-375, 2009.
24. Yamamura K, Ohishi K, Katayama N, Yu Z, Kato K, Masuya M, Fujieda A, Sugimoto Y, Miyata E, Shibasaki T, Heike Y, Takaue Y and Shiku H: Pleiotropic role of histone deacetylases in the regulation of human adult erythropoiesis. Br J Haematol 135: 242-253, 2006. (Pubitemid 44401623)
25. Kawano Y, Kobune M, Yamaguchi M, Nakamura K, Ito Y, Sasaki K, Takahashi S, Nakamura T, Chiba H, Sato T, Matsunaga T, Azuma H, Ikebuchi K, Ikeda H, Kato J, Niitsu Y and Hamada H: Ex vivo expansion of human umbilical cord hematopoietic progenitor cells using a coculture system with human telomerase catalytic subunit (hTERT)-transfected human stromal cells. Blood 101: 532-540, 2003. (Pubitemid 36077574)
26. Nosaka T and Kitamuta T: Pim-1 expression is sufficient to induce cytokine independence in murine hematopoietic cells, but is dispensable for BCR-ABL-mediated transformation. Exp Hematol 30: 697-702, 2002. (Pubitemid 34831689)
27. Onishi M, Nosaka T, Misawa K, Mui ALF, Gorman D, McMahon M, Miyajima A and Kitamura T: Identification and characterization of a constitutively active STAT5 mutant that promotes cell proliferation. Mol Cell Biol 18: 3871-3879, 1998. (Pubitemid 28287910)
28. Kitamura T, Koshino Y, Shibata F, Oki T, Nakajima H, Nosaka T and Kumagai H: Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics. Exp Hematol 31: 1007-1014, 2003. (Pubitemid 37329742)
29. Pegoraro L, Matera L, Ritz J, Levis A, Palumbo A and Biagini G: Establishment of a Ph1-positive human cell line (BV173). J Natl Cancer Inst 70: 447-453, 1983. (Pubitemid 13117191)
30. Ono R, Kumagai H, Nakajima H, Hishiya A, Taki T, Horikawa K, Takatsu K, Satoh T, Hayashi Y, Kitamura T and Nosaka T: Mixed-lineage-leukemia (MLL) fusion protein collaborates with Ras to induce acute leukemia through aberrant Hox expression and Raf activation. Leukemia 23: 2197-2209, 2009.
31. Ono R, Nakajima H, Ozaki K, Kumagai H. Kawashima T, Taki T, Kitamura T, Hayashi Y and Nosaka T: Dimerization of MLL fusion proteins and FLT3 activation synergize to induce multiple-lineage leukemogenesis. J Clin Invest 115: 919-929, 2005. (Pubitemid 40489396)
32. Nosaka T, Kawashima T, Misawa K, Ikuta K, Mui AL-F and Kitamura T: STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells. EMBO J 18: 4754-4765, 1999. (Pubitemid 29415529)
33. Trageser D, Iacobucci I, Nahar R, Duy C, von Levetzow G, Klemm L, Park E, Schuh W, Gruber T, Herzog S, Kim Y-M, Hofmann W-K, Li A, Storlazzi CT, Jäck H-M, Groffen J, Martinelli G, Heisterkamp N, Jumaa H and Müschen M: Pre-B cell receptor-mediated cell cycle arrest in Philadelphia chromosome-positive acute lymphoblastic leukemia requires IKAROS function. J Exp Med 206: 1739-1753, 2009.
34. Perrotti D, Jamieson C, Goldman J and Skorski T: Chronic myeloid leukemia: mechanisms of blastic transformation. J Clin Invest 120: 2254-2264, 2010.